ESR2 and ovarian carcinoma: In this report we have studied the role and effect of ERα and ERβ in response to the natural hormone estradiol (E2) and the subtype-selective agonists PPT (ERα-selective) and KB9520 (ERβ-selective) in the human ovarian cancer cell lines SKOV3 and A2780cis.